These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27428427)

  • 21. IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.
    Lee S; Andrieu C; Saltel F; Destaing O; Auclair J; Pouchkine V; Michelon J; Salaun B; Kobayashi R; Jurdic P; Kieff ED; Sylla BS
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17416-21. PubMed ID: 15574499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
    Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
    Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
    Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
    Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.
    Saulnier A; Vaissière T; Yue J; Siouda M; Malfroy M; Accardi R; Creveaux M; Sebastian S; Shahzad N; Gheit T; Hussain I; Torrente M; Maffini FA; Calabrese L; Chiesa F; Cuenin C; Shukla R; Fathallah I; Matos E; Daudt A; Koifman S; Wünsch-Filho V; Menezes AM; Curado MP; Zaridze D; Boffetta P; Brennan P; Tommasino M; Herceg Z; Sylla BS
    Int J Cancer; 2012 Jun; 130(11):2484-94. PubMed ID: 21796618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
    Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
    Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
    PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.
    Woodring PJ; Meisenhelder J; Johnson SA; Zhou GL; Field J; Shah K; Bladt F; Pawson T; Niki M; Pandolfi PP; Wang JY; Hunter T
    J Cell Biol; 2004 May; 165(4):493-503. PubMed ID: 15148308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
    Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
    BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
    Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
    BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.
    Siouda M; Yue J; Shukla R; Guillermier S; Herceg Z; Creveaux M; Accardi R; Tommasino M; Sylla BS
    Mol Cell Biol; 2012 Dec; 32(23):4877-90. PubMed ID: 23028047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
    Coppin E; De Grandis M; Pandolfi PP; Arcangeli ML; Aurrand-Lions M; Nunès JA
    J Immunol; 2016 May; 196(10):4110-21. PubMed ID: 27183638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
    Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ
    Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.
    Li T; Li B; Sara A; Ay C; Leung WY; Zhang Y; Dong Y; Liang Q; Zhang X; Weidner P; Gutting T; Behrens HM; Röcken C; Sung JJ; Ebert MP; Yu J; Burgermeister E
    Oncoimmunology; 2019; 8(11):e1649961. PubMed ID: 31646096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrin phosphorylation switch: the effect of beta3 integrin tail phosphorylation on Dok1 and talin binding.
    Oxley CL; Anthis NJ; Lowe ED; Vakonakis I; Campbell ID; Wegener KL
    J Biol Chem; 2008 Feb; 283(9):5420-6. PubMed ID: 18156175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing.
    Laletin V; Bernard PL; Montersino C; Yamanashi Y; Olive D; Castellano R; Guittard G; Nunès JA
    Sci Rep; 2024 Jul; 14(1):15053. PubMed ID: 38956389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer.
    Kwon KA; Yun J; Oh SY; Seo BG; Lee S; Lee JH; Kim SH; Choi HJ; Roh MS; Kim HJ
    Cancer Res Treat; 2016 Jan; 48(1):198-207. PubMed ID: 26130665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.